ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured vs LIC Healthcare Fund - Regular Plan - Growth
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured |  LIC Healthcare Fund - Regular Plan - Growth | |
|---|---|---|
| NAV | ₹43.43 | ₹33.8472 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +7.31% | +14.37% |
| 3 year (p.a.) | +22.09% | +20.88% |
| 5 year (p.a.) | +15.97% | +11.99% |
| Expense ratio | 1.56% | 2.10% |
| Fund size | ₹6,624.58 Cr | ₹92.55 Cr |
| Risk | Very high | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.